Authors/Disclosures
|
Mauricio R. Delgado, MD, FRCPC, FAAN
|
Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv. The institution of Dr. Delgado has received research support from Ipsen. |
|
Ann H. Tilton, MD, FAAN
(LSUHSC and Childrens Hospital of New Orleans)
|
Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Philippe Picaut
|
No disclosure on file |
|
Daniel B. Snyder, PhD
(Revance Therapeutics Inc.)
|
No disclosure on file |
|
Marinella Clerico, MD
(University of Torino)
|
Dr. Clerico has nothing to disclose. |
|
Stefania Battistini, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |